Skip to main content
Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0370
+0.0370 (0.00%)
Apr 25, 2025, 4:00 PM EDT

PLSH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
2.762.381.632.069.022.2
Revenue Growth (YoY)
50.38%46.59%-21.01%-77.16%310.19%-
Cost of Revenue
6.636.476.196.4811.473.88
Gross Profit
-3.87-4.09-4.56-4.42-2.45-1.68
Selling, General & Admin
1.451.461.091.522.810.99
Operating Expenses
1.451.461.091.522.810.99
Operating Income
-5.31-5.55-5.65-5.94-5.26-2.67
Interest Expense
-1.61-1.56-2.05-1.11-1.51-0.43
Other Non Operating Income (Expenses)
0.150.180.260.240.250.66
EBT Excluding Unusual Items
-6.76-6.92-7.44-6.81-6.52-2.45
Gain (Loss) on Sale of Investments
-0.91-1.09-2.641.171.430.13
Gain (Loss) on Sale of Assets
----0.3-0.14-0.49
Other Unusual Items
-00.941.15--
Pretax Income
-7.67-8.02-9.14-4.78-5.23-2.81
Net Income
-7.67-8.02-9.14-4.78-5.23-2.81
Net Income to Common
-7.67-8.02-9.14-4.78-5.23-2.81
Shares Outstanding (Basic)
171715181718
Shares Outstanding (Diluted)
171715181718
Shares Change (YoY)
18.33%11.88%-16.60%5.35%-4.90%-
EPS (Basic)
-0.45-0.48-0.62-0.27-0.31-0.16
EPS (Diluted)
-0.45-0.48-0.62-0.27-0.31-0.16
Free Cash Flow
-1.62-1.59-2.64-4.09-10.85-10.87
Free Cash Flow Per Share
-0.10-0.10-0.18-0.23-0.64-0.61
Gross Margin
-139.86%-171.48%-280.20%-214.53%-27.19%-76.56%
Operating Margin
-192.25%-232.55%-347.41%-288.26%-58.31%-121.42%
Profit Margin
-277.51%-336.08%-561.94%-232.20%-58.02%-127.88%
Free Cash Flow Margin
-58.71%-66.66%-162.47%-198.34%-120.28%-494.42%
EBITDA
-3.64-3.83-3.92-4.2-3.57-1.87
EBITDA Margin
-131.68%-160.72%-241.01%-203.92%-39.54%-85.28%
D&A For EBITDA
1.671.711.731.741.690.79
EBIT
-5.31-5.55-5.65-5.94-5.26-2.67
EBIT Margin
-192.25%-232.55%--288.26%-58.31%-121.42%
Advertising Expenses
-0.020.210.381.50.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.